
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.80%
+2.02%
-3.41%
+1.49%
-4.59%
Most Trending
-1.80%
+2.02%
-3.41%
+1.49%
-4.59%
16 Dec 2025$GOOG Alphabet closed modestly lower amid heavy debate around valuation versus long-term AI leadership. Bulls focused on its dominant position in search, cloud, and applied AI monetization, while bears pointed to stretched multiples and incremental regulatory scrutiny as near-term headwinds.
$KHC Kraft Heinz traded higher after announcing Steve Cahillane as the next CEO, a move the market interpreted as a step toward strategic clarity ahead of a potential split. Investors welcomed leadership continuity and optionality around portfolio simplification.
$HAL Halliburton underperformed as energy services names faced pressure, even as quantitative models continued to flag the stock as fundamentally attractive for value-oriented investors willing to stomach cyclicality.
$CVE Cenovus Energy sold off sharply despite a wave of reiterated Buy and Outperform ratings from major brokerages. The disconnect reflected broader energy sector weakness rather than company-specific deterioration, keeping the undervaluation narrative intact.
$AFRM Affirm surged on strong momentum and elevated options activity, signaling aggressive positioning around consumer spending resilience and the company’s role in buy-now-pay-later adoption.
$KO Coca-Cola slipped slightly as investors balanced its defensive dividend appeal against near-term growth expectations, with long-term holders still leaning on its predictable cash flows and brand strength.
$GIS General Mills traded flat ahead of its upcoming earnings, with the market waiting to see whether recent margin pressures ease and consumer demand trends stabilize.
$CTSH Cognizant moved quietly as investors digested mixed analyst views alongside news of a new multi-year IT services agreement, reinforcing its steady but unspectacular AI-driven transformation.
$AZN AstraZeneca eased despite regulatory wins, including FDA and EU approvals, as traders locked in gains while longer-term growth investors continued to favor its expanding oncology and immunology pipeline.
$LEN Lennar declined after mixed quarterly results and cautious guidance, highlighting ongoing sensitivity to interest rates and housing affordability despite resilient demand pockets.
$AKTX Akari Therapeutics plunged after announcing a $5 million financing, with dilution concerns overwhelming optimism around its oncology pipeline.
$BUD Anheuser-Busch InBev edged lower as analysts reiterated mostly positive ratings, reflecting confidence in long-term upside even as near-term volume trends remain uneven.
$DDOG Datadog held steady as Wall Street maintained a constructive long-term view, betting that its platform breadth can reaccelerate growth after a sharp drawdown.
$HUM Humana fell after reaffirmed EPS guidance missed consensus expectations, reviving concerns around cost pressures in managed care.
$FER Ferrovial traded flat as conflicting analyst recommendations underscored uncertainty around valuation following recent infrastructure asset moves.
$AEP American Electric Power slipped modestly despite a higher price target from JPMorgan, as utilities broadly lagged in a higher-rate environment.
$DLTH Duluth Holdings collapsed after earnings, with revenue misses and guidance concerns overshadowing progress on cost controls and margin improvement.
$INTU Intuit advanced as investors continued to reward its consistent execution and long-term SaaS growth profile, reinforcing its status as a core holding for quality-focused portfolios.
01:02 PM
11:12 AM
08:52 AM
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.